Otogenic cranial base osteomyelitis: A proposed prognosis-based system for disease classification

Otology and Neurotology

Volumn 29, Issue 5, 2008, Pages 666-672

  Lee, Stewart ^a,b   Hooper, Robin ^a   Fuller, Andrew ^c   Turlakow, Alla ^a   Cousins, Vincent ^a   Nouraei, Reza ^b  

^a ALFRED HOSPITAL   (Australia)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c Departments of Infectious Diseases   (Argentina)

Author keywords

Cranial base osteomyelitis; Malignant otitis externa; Necrotizing external otitisVSPECT

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; TECHNETIUM 99M; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CRANIAL NEUROPATHY; DEMOGRAPHY; DIABETIC PATIENT; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; HYPERBARIC OXYGEN; IMMUNOCOMPROMISED PATIENT; MALE; MASTOID; MICROBIOLOGY; MIXED INFECTION; MORBIDITY; MORTALITY; MYCOSIS; OSTEOMYELITIS; OTALGIA; OTORRHEA; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PSEUDOMONAS AERUGINOSA; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKULL BASE OSTEOMYELITIS; SKULL SURGERY; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TEMPORAL BONE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; CLASSIFICATION; EXTERNAL OTITIS; ISOLATION AND PURIFICATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSEUDOMONAS INFECTION; SCINTISCANNING; SECRETORY OTITIS MEDIA; SKULL BASE;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOMYELITIS; OTITIS EXTERNA; OTITIS MEDIA WITH EFFUSION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SKULL BASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 58149399686     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318179972f     Document Type: Article

References (15)

1. Bernheim J, Sade J. Histopathology of the soft parts in 50 patients with malignant external otitis. J Laryngol Otol 1989;103:366-8.
2. Chandler J. Malignant external otitis. Laryngoscope 1968;78: 1257-94.
3. Sreepadaa G, Kwartlerb J. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg 2003;11:316-23.
4. Wright D, Alexander J. Effects of water on bacterial flora of swimmer's ear. Arch Otolaryngol 1974;99:15-8.
5. Slattery W, Brackmann D. Skull base osteomyelitis: malignant external otitis. Otolaryngol Clin North Am 1996;29:795-806.
6. Benecke J. Management of osteomyelitis of the skull base. Laryngoscope 1989;99:1220-3.
7. Corey J, Levandowski R, Panwalker A. Prognostic implications of therapy for necrotizing external otitis. Am J Otol 1985;6:353-8.
8. Davies J, Gates G, Lermer C. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 1992;118:89-93.
9. Levenson M, Parisier S, Dolitsky J, et al. Ciprofloxacin: drug of choice in the treatment of malignant external otitis. Laryngoscope 1991;101:821-4.
10. Hall W, Ramachandran R, Narayan S, et al. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 2004;4:94.
11. Toulmouche M. Observations d'otorhee cerebrale suivis des reflexions. Gaz Med Paris 1838;6:422.
12. Meltzer P, Kelemen G. Pyocutaneous osteomyelitis of the temporal bone, mandible and zygoma. Laryngoscope 1959;69:1300-16.
13. Rubin J, Yu Y. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med 1988;85:391-8.
14. Rubin J, Stoehr G, Yu VL, et al. Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg 1989;115:1063-9.
15. Berenholz L, Katzenell U, Harrel M. Evolving resistance to cipro-floxacin in malignant otitis externa. Laryngoscope 2002;112: 1619-21.